Sowell Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Sowell Financial Services’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$313K	Buy	502 +6	+1%	+$4.08K	0.01%	858
2026 Q1	$383K	Buy	496 +77	+18%	+$59K	0.01%	733
2025 Q4	$324K	Buy	419 +3	+0.7%	+$2.04K	0.01%	807
2025 Q3	$234K	Sell	416 -167	-29%	-$94.4K	0.01%	924
2025 Q2	$306K	Buy	583 +26	+5%	+$14.5K	0.01%	779
2025 Q1	$353K	Buy	+557	New	+$383K	0.02%	695
2021 Q2	–	Sell	-376	Closed	-$188K	–	2224
2021 Q1	$188K	Sell	376 -126	-25%	-$61.3K	0.01%	1086
2020 Q4	$243K	Sell	502 -140	-22%	-$75.6K	0.01%	774
2020 Q3	$359K	Sell	642 -864	-57%	-$524K	0.02%	558
2020 Q2	$939K	Buy	1,506 +1,039	+222%	+$590K	0.05%	289
2020 Q1	$228K	Sell	467 -60	-11%	-$24.7K	0.02%	616
2019 Q4	$198K	Buy	527 +179	+51%	+$60.2K	0.02%	718
2019 Q3	$97K	Buy	+348	New	+$103K	0.01%	841

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Sowell Financial Services's REGN Position: Q2 2026 in Review

Sowell Financial Services increased its Regeneron Pharmaceuticals (REGN) stake by 1.2% in Q2 2026, buying an estimated $4.08K and bringing the position to 502 shares worth $313K. The position accounts for 0.01% of the portfolio, ranked #858.

Sowell Financial Services first reported a position in REGN in Q3 2019 and has held it in 13 quarters since. The position peaked at $939K in Q2 2020. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Sowell Financial Services held 502 shares of Regeneron Pharmaceuticals worth $313K as of Q2 2026.
Sowell Financial Services bought 6 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $4.08K.
Regeneron Pharmaceuticals made up 0.01% of Sowell Financial Services's portfolio in Q2 2026, its #858 holding.
Sowell Financial Services first reported a position in Regeneron Pharmaceuticals in Q3 2019 and has held it in 13 quarters since.
Sowell Financial Services's Regeneron Pharmaceuticals position peaked at $939K in Q2 2020.
1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Sowell Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.